Multi-Institutional Analysis of Synchronous Prostate and Rectosigmoid Cancers
Conclusions: Synchronous rectosigmoid cancer is a greater contributor to mortality than prostate cancer. Men aged ≥45 with localized prostate cancer should undergo colorectal cancer screening prior to treatment to evaluate for synchronous rectosigmoid cancer.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Colorectal Cancer | Gastroenterology | Neoadjuvant Therapy | Prostate Cancer | Prostatectomy | Study | Toxicology